Clinical effects of a microdose GnRH agonist flare regimen administered to poor responders undergoing ART cycles

Acta Medica Iranica

Volumn 47, Issue 4, 2009, Pages 263-267

  Davar, Robab ^a   Aflatoonian, Abbas ^a   Asgharnia, Maryam ^b  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

IVF ICSI; Microdose GnRH a; Poor responders

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; LOW DOSE ORAL CONTRACEPTIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO; FEMALE; FERTILIZATION IN VITRO; GROUPS BY AGE; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; IRAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY INSUFFICIENCY; PREGNANCY RATE; TREATMENT OUTCOME;

EID: 71849091312     PISSN: 00446025     EISSN: 00446025     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Porter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins. Lancet 1984; 2(8414): 1284-1285 (Pubitemid 15217748)
2. Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu HC, et al. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril 1989; 51(2): 292-297 (Pubitemid 19050530)
3. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992; 58(5): 888-896
4. Leondires MP, Escalpes M, Segars JH, Scott RT Jr, Miller BT. Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. Fertil Steril 1999; 72(6): 1018-1023
5. Filicori M, Flamigni C, Cognigni G, Dellai P, Arnone R, Falbo A, et al. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women. J Clin Endocrinol Metab 1993; 77(1): 130-133 (Pubitemid 23206790)
6. Balasch J, Jové IC, Moreno V, Civico S, Puerto B, Vanrell JA. The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program. Fertil Steril 1992; 58(5): 991-994
7. Garcia JE, Padilla SL, Bayati J, Baramki TA. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990; 53(2): 302-305 (Pubitemid 20076360)
8. Tan SL, Kingsland C, Campbell S, Mills C, Bradfield J, Alexander N, et al. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization. Fertil Steril 1992; 57(4): 810-814
9. Acharya U, Small J, Randall J, Hamilton M, Templeton A. Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program. Fertil Steril 1992; 57(4): 815-818
10. Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril 2000; 73(4): 667-676
11. Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994; 61(5): 880-885 (Pubitemid 24136854)
12. Jansen CAM, Tucker KE. Microdose GnRH for the stimulation of low responders. In: Allahbadia GN, Basuray Das R, editors. The Art and Science of Assisted Reproductive Techniques (ART). London: Taylor and Francis; 2003. p. 73-76
13. Kanzepolsky LS, de Fried EP. A randomized, prospective study of microdose leuprolide versus oocyte donation in poor response patients. Fertil Steril. 2003; 80(3):192.
14. Detti L, Williams DB, Robins JC, Maxwell RA, Thomas MA. A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization. Fertil Steril 2005; 84(5): 1401-1405 (Pubitemid 41571887)
15. Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 1997; 67(1): 93-97 (Pubitemid 26428419)
16. Sharara FI, McClamrock HD. A modified microdose GnRHa/Gonadotrophin protocol for ovarian stimulation in IVF: experience in 102 cycles. Middle East Fertil Soc J 2000; 5: 204-208
17. Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998; 69(3): 419-424 (Pubitemid 28146550)
18. Silverberg K, Ormand R, Hansard L. Ultra- Low dose Lupron flare shows promising results for poor IVF responders. American Society for Reproductive Medicine (ASRM) Conference. Canada: Toronto, Ontario, 1999.
19. Weissman A, Shoham Z. GnRH and its agonistic analogues: basic knowledge. In: Shoham Z, Howles CM, Jacobs HS, editors. Female Infertility Therapy: Current Practice. London: Martin Dunitz Ltd; 1999. p. 155-166
20. Akman MA, Erden HF, Tosun SB, Bayazit N, Aksoy E, Bahceci M. Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001; 16(5): 868-870 (Pubitemid 32451819)
21. Sharara FI, McClamrock HD. Use of microdose GnRH agonist protocol in women with low ovarian volumes undergoing IVF. Hum Reprod 2001; 16(3): 500-503 (Pubitemid 32218801)